跳至主要内容
临床试验/NCT02714673
NCT02714673Unknown不适用

Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement

Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2016年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
600
试验地点
1
主要终点
a composite criteria including the occurrence of one or more bleeding complications, major thrombotic events, or reoperation for any reason

研究概览

简要总结

It is a multicenter, prospective, observational study of standard care. This study analyses the care of patients on long term effective anticoagulation therapy (ADELC) during a primary hip or knee arthroplasty.

The objectives of the study are to:

  1. Identify clinical practices set up for patient care
  2. Assess the type and the frequency of perioperative complications
  3. Look for factors, related to patients or treatments, associated with the occurrence of these complications.

The main objective is to estimate the risks, adjusted and not, of postoperative complications associated to a long term anticoagulation by comparing patients under anticoagulation to a control group of patients having the same interventions but who are not under anticoagulation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult ≥ 18 years
  • Programmed for primary hip or knee arthroplasty.
  • Effective dose of anticoagulant drugs intake for more than 1 month with the intention to resume it after the intervention for ADELC cohort; no effective dose of anticoagulant drugs intake for the control cohort.

排除标准

  • Patient non opposition

研究组 & 干预措施

ADELC

Cohort of patients on long term anticoagulation and undergoing a primary hip or knee replacement.

干预措施: anticoagulation (Drug)

结局指标

主要结局

a composite criteria including the occurrence of one or more bleeding complications, major thrombotic events, or reoperation for any reason

时间窗: up to 3 months

次要结局

  • The occurrence of a complication of grade 2 or more from Dindo and Clavien classification .(within 12 months)
  • The proportion of patients who are transfused during the hospitalization(up to day 15)
  • The length of hospital stay(until end of study, an expected 12 months)

研究者

发起方
Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr David BIAU

Associate Professor

Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique

研究点 (1)

Loading locations...

相似试验